mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | USA300TCH1516_ALE | 512,643 | 0 | A | G | 50.0% | ‑6.0 / 62.9 | 42 | intergenic (+711/‑6052) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
| * | USA300TCH1516_ALE | 111,512 | 0 | A | G | 45.5% | 7.0 / 42.3 | 33 | S194S (TCA→TCG) | USA300HOU_RS00520 | putative lipoprotein |
| * | USA300TCH1516_ALE | 111,516 | 0 | C | A | 45.2% | 18.8 / 37.4 | 31 | Q196K (CAA→AAA) | USA300HOU_RS00520 | putative lipoprotein |
| * | USA300TCH1516_ALE | 2,663,581 | 0 | C | T | 35.3% | 13.3 / 12.5 | 17 | G167E (GGA→GAA) | USA300HOU_RS13705 | hypothetical protein |
| * | USA300TCH1516_ALE | 2,663,592 | 0 | A | T | 30.0% | 26.6 / 14.2 | 20 | P163P (CCT→CCA) | USA300HOU_RS13705 | hypothetical protein |
| * | USA300TCH1516_ALE | 2,490,047 | 0 | T | A | 26.1% | 39.7 / 14.6 | 23 | G129G (GGA→GGT) | USA300HOU_RS12815 | putative lipoprotein |
| * | USA300TCH1516_ALE | 2,490,056 | 0 | C | T | 26.1% | 36.0 / 11.5 | 23 | P126P (CCG→CCA) | USA300HOU_RS12815 | putative lipoprotein |
| * | USA300TCH1516_ALE | 2,490,083 | 0 | G | T | 25.0% | 46.9 / 11.9 | 25 | A117A (GCC→GCA) | USA300HOU_RS12815 | putative lipoprotein |
| * | USA300TCH1516_ALE | 2,490,077 | 0 | C | T | 24.0% | 41.7 / 11.5 | 25 | P119P (CCG→CCA) | USA300HOU_RS12815 | putative lipoprotein |
| * | USA300TCH1516_ALE | 2,789,594 | 0 | T | . | 23.5% | 41.3 / 11.0 | 17 | intergenic (+26/‑51) | manR_2/manP | Transcriptional regulator ManR/PTS system mannose‑specific EIIBCA component |
| * | USA300TCH1516_ALE | 2,790,982 | 0 | A | G | 22.9% | 55.1 / 17.8 | 35 | I446M (ATA→ATG) | manP | PTS system mannose‑specific EIIBCA component |
| * | USA300TCH1516_ALE | 2,490,071 | 0 | T | A | 22.2% | 56.4 / 11.3 | 27 | A121A (GCA→GCT) | USA300HOU_RS12815 | putative lipoprotein |
| * | USA300TCH1516_ALE | 2,490,074 | 0 | A | C | 22.2% | 36.2 / 16.8 | 27 | V120V (GTT→GTG) | USA300HOU_RS12815 | putative lipoprotein |
| * | USA300TCH1516_ALE | 2,490,086 | 0 | A | G | 22.2% | 46.1 / 12.2 | 27 | N116N (AAT→AAC) | USA300HOU_RS12815 | putative lipoprotein |
| * | USA300TCH1516_ALE | 1,845,634 | 0 | G | A | 20.7% | 59.0 / 11.1 | 29 | F620F (TTC→TTT) | isdH | Iron‑regulated surface determinant protein H |
| * | USA300TCH1516_ALE | 1,213,574 | 0 | A | T | 20.0% | 55.5 / 11.3 | 25 | T244T (ACA→ACT) | carB | Carbamoyl‑phosphate synthase large chain |